Allergan Ordered To Prove Tribe Patent Deal Isn’t A ‘Sham’

Law360, New York (October 10, 2017, 2:42 PM EDT) -- Allergan Inc. needs to prove that its controversial transfer of four patents for the dry eye treatment Restasis to the Saint Regis Mohawk Tribe was more than a “sham” before the tribe can be added to infringement litigation against Teva, Mylan and others, a federal judge in Texas said.

Senior U.S. Circuit Judge William C. Bryson, sitting in Texas district court, on Friday ordered the competing drugmakers to submit briefs outlining why the tribe belongs in the suit, “or whether the assignment of the patents to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.